Stocken  Invest AS, a wholly  owned company by Lars  Viksmoen, has on 18 October
2019 transferred  12,966 shares in  PCI Biotech  Holding ASA  ("PCI Biotech") to
Lars Viksmoen, board member of PCI Biotech, at an average price of NOK 26.80 per
share.

After  the transaction,  Lars Viksmoen  holds 12,966 shares  in PCI  Biotech and
Stocken Invest AS holds 0 shares in PCI Biotech.

This  information is subject to the  disclosure requirements pursuant to section
4-2 of the Norwegian Securities Trading Act.